Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
ICON plc (NASDAQ: ICLR) and Mural Health Technologies have announced a strategic partnership to implement Mural Link, a comprehensive participant management and payments platform for clinical trials. The collaboration aims to enhance trial participation experience and efficiency.
Through this partnership, ICON will leverage Mural Link's features including:
- Clinical trial participant payment systems
- Tax management capabilities
- Travel and concierge support
- Site-participant communication tools
- Advanced reporting and analytics
A key highlight is Mural Health's fee-free debit card option, designed to eliminate financial barriers to trial participation. The partnership focuses on increasing the recruitable patient population, particularly among historically underrepresented groups, while reducing participant-level operational challenges that contribute to patient attrition.
ICON plc (NASDAQ: ICLR) e Mural Health Technologies hanno annunciato una partnership strategica per implementare Mural Link, una piattaforma completa di gestione dei partecipanti e dei pagamenti per le sperimentazioni cliniche. La collaborazione mira a migliorare l'esperienza di partecipazione alle prove e l'efficienza.
Attraverso questa partnership, ICON sfrutterà le funzionalità di Mural Link, tra cui:
- Sistemi di pagamento per i partecipanti alle sperimentazioni cliniche
- Capacità di gestione fiscale
- Supporto per viaggi e servizi di concierge
- Strumenti di comunicazione tra siti e partecipanti
- Reportistica avanzata e analisi
Un punto saliente è l'opzione della carta di debito senza commissioni di Mural Health, progettata per eliminare le barriere finanziarie alla partecipazione alle prove. La partnership si concentra sull'aumento della popolazione di pazienti reclutabili, in particolare tra i gruppi storicamente sottorappresentati, riducendo al contempo le sfide operative a livello di partecipante che contribuiscono all'abbandono dei pazienti.
ICON plc (NASDAQ: ICLR) y Mural Health Technologies han anunciado una asociación estratégica para implementar Mural Link, una plataforma integral de gestión de participantes y pagos para ensayos clínicos. La colaboración tiene como objetivo mejorar la experiencia de participación en los ensayos y la eficiencia.
A través de esta asociación, ICON aprovechará las características de Mural Link, que incluyen:
- Sistemas de pago para participantes de ensayos clínicos
- Capacidades de gestión fiscal
- Soporte para viajes y servicios de concierge
- Herramientas de comunicación entre sitios y participantes
- Informes avanzados y análisis
Un aspecto destacado es la opción de tarjeta de débito sin comisiones de Mural Health, diseñada para eliminar las barreras financieras a la participación en ensayos. La asociación se centra en aumentar la población de pacientes reclutables, especialmente entre grupos históricamente subrepresentados, al tiempo que reduce los desafíos operativos a nivel de participante que contribuyen a la deserción de pacientes.
ICON plc (NASDAQ: ICLR)와 Mural Health Technologies는 임상 시험을 위한 포괄적인 참여자 관리 및 결제 플랫폼인 Mural Link를 구현하기 위한 전략적 파트너십을 발표했습니다. 이번 협력은 시험 참여 경험과 효율성을 향상시키는 것을 목표로 합니다.
이 파트너십을 통해 ICON은 Mural Link의 기능을 활용할 예정입니다. 기능에는 다음이 포함됩니다:
- 임상 시험 참여자 결제 시스템
- 세금 관리 기능
- 여행 및 컨시어지 지원
- 사이트-참여자 간의 커뮤니케이션 도구
- 고급 보고 및 분석
주요 하이라이트는 Mural Health의 수수료 없는 직불 카드 옵션으로, 이는 시험 참여에 대한 재정적 장벽을 없애기 위해 설계되었습니다. 이 파트너십은 특히 역사적으로 저대표된 그룹 사이에서 모집 가능한 환자 수를 늘리고, 환자 이탈에 기여하는 참여자 수준의 운영 문제를 줄이는 데 중점을 두고 있습니다.
ICON plc (NASDAQ: ICLR) et Mural Health Technologies ont annoncé un partenariat stratégique pour mettre en œuvre Mural Link, une plateforme complète de gestion des participants et des paiements pour les essais cliniques. La collaboration vise à améliorer l'expérience de participation aux essais et l'efficacité.
Grâce à ce partenariat, ICON tirera parti des fonctionnalités de Mural Link, notamment :
- Systèmes de paiement pour les participants aux essais cliniques
- Capacités de gestion fiscale
- Support pour les voyages et services de conciergerie
- Outils de communication entre sites et participants
- Rapports avancés et analyses
Un point fort est l'option de carte de débit sans frais de Mural Health, conçue pour éliminer les barrières financières à la participation aux essais. Le partenariat se concentre sur l'augmentation de la population de patients recrutables, en particulier parmi les groupes historiquement sous-représentés, tout en réduisant les défis opérationnels au niveau des participants qui contribuent à l'abandon des patients.
ICON plc (NASDAQ: ICLR) und Mural Health Technologies haben eine strategische Partnerschaft zur Implementierung von Mural Link, einer umfassenden Plattform für Teilnehmermanagement und Zahlungen für klinische Studien, angekündigt. Die Zusammenarbeit zielt darauf ab, die Erfahrung und Effizienz der Teilnahme an Studien zu verbessern.
Durch diese Partnerschaft wird ICON die Funktionen von Mural Link nutzen, darunter:
- Zahlungssysteme für Teilnehmer klinischer Studien
- Steuerverwaltungsfunktionen
- Reise- und Concierge-Support
- Kommunikationstools zwischen Standorten und Teilnehmern
- Erweiterte Berichterstattung und Analysen
Ein wichtiges Highlight ist die gebührenfreie Debitkartenoption von Mural Health, die darauf abzielt, finanzielle Barrieren für die Teilnahme an Studien zu beseitigen. Die Partnerschaft konzentriert sich darauf, die rekrutierbare Patientengruppe zu erhöhen, insbesondere unter historisch unterrepräsentierten Gruppen, während gleichzeitig operationale Herausforderungen auf Teilnehmer-Ebene, die zur Abwanderung von Patienten beitragen, verringert werden.
- Enhanced patient recruitment potential through removal of financial barriers
- Streamlined operational efficiency for clinical trial sites
- Expanded payment options including fee-free debit card
- Improved access to underrepresented patient populations
- None.
BERWYN, Pa. and
ICON will utilize Mural Link's innovative functionality related to clinical trial participant payments, tax management, travel and concierge support, site-participant communication tools, and novel reporting and analytics capabilities.
"From our very first conversations with ICON, we were highly impressed by their commitment to patient care and innovation," said Sam Whitaker, CEO of Mural Health. "This partnership represents a shared vision of removing barriers to trial participation and advancing participation financial neutrality, while eliminating the need for site staff to manage highly manual, error-prone, and time-consuming administrative activities."
Mural Health's novel operating model and diverse payment options, including the industry's only fee-free debit card option, will assist ICON to eliminate significant financial barriers that prevent trial participation. ICON's customers will benefit from an increase in the total recruitable patient population, including large communities of historically underrepresented patient populations, and a reduction in participant-level operating challenges that drive patient-attrition.
"Mural Health's range of payment methods, unique approach to payment structure, and introduction of a fee-free participant environment are important additions to how we deliver care to patients," said Dr Gareth Milborrow, Executive Vice President, Business Operations, ICON. "We look forward to bringing these to our customers and, importantly, to delivering very tangible benefits to our patients and sites."
About ICON plc
ICON is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in
About Mural Health
Mural Health stands at the forefront as a patient-first technology innovator, devoted to simplifying clinical research engagement. The company targets areas ripe for significant enhancement, providing technological solutions designed to ease participation burdens for patients and caregivers alike, both locally and globally. With products like Mural Link, which streamlines participant payments, travel coordination, communication, and satisfaction measurement, Mural Health is dedicated to improving the clinical trial experience. For further information about Mural Health, visit https://www.muralhealth.com/
View original content:https://www.prnewswire.com/news-releases/mural-health-and-icon-announce-partnership-to-enhance-participant-and-site-experience-in-clinical-trials-302391350.html
SOURCE Mural Health
FAQ
What features will ICON plc (ICLR) gain through the Mural Health partnership?
How will the Mural Health partnership affect ICON's (ICLR) clinical trial recruitment?
What unique payment solution does Mural Health offer in the ICON (ICLR) partnership?
How will the Mural Health platform impact ICON's (ICLR) clinical trial site operations?
